Management of uterine leiomyomas in perimenopausal women.
YE Ming-zhu，DENG Xin-liang，XUE Min.
Chinese Journal of Practical Gynecology and Obstetrics ›› 2016, Vol. 32 ›› Issue (2) : 126-131.
Management of uterine leiomyomas in perimenopausal women.
Abstract:Uterine leiomyomas are the most common benign tumor of female reproductive organs，and they are more likely to be found in perimenopausal women.Because of the unique physiological characteristics of female perimenopausal period，the management of uterine leiomyomas in perimenopausal women also has special strategies.This article summarized the clinical and pathologic features of uterine leiomyomas，and the physiological characteristics of perimenopausal women，and introduced the different treatments for leiomyomas and stategies to make a reasonable choice.
[1] 曹泽毅，郎景和，王临红，等. 中华妇产科学[M]. 3版.北京：人民卫生出版社，2014：2224-2242.
[2] Khan AT，Shehmar M，Gupta JK.Uterine fibroids：current perspectives[J].Int J Womens Health，2014，6(6)：95-114.
[3] Islam MS，Protic O，Stortoni P，et al. Complex networks of multiple factors in the pathogenesis of uterine leiomyoma[J]. Fertil Steril，2013，100(1)：178-193.
[4] Munro MG，Critchley HOD，Broder MS，et al. The FIGO Classification System (“PALM-COEIN”) for causes of abnormal uterine bleeding in non-gravid women in the reproductive years，including guidelines for clinical investigation[J]. Int J Gynaecol Obstet，2011，113(1)：3-13.
[5] 刘云嵘. 90年代绝经研究[M]．北京：人民卫生出版社，1998：11-12.
[6] Peddada SD，Laughlin SK，Miner K，et al. Growth of uterine leiomyomata among premenopausal black and white women[J]. Proc Natl Acad Sci USA，2008，105(50)：19887-19892.
[7] De Waay DJ，Syrop CH，Nygaard IE，et al. Natural history of uterine polyps and leiomyomata[J]. Obstet Gynecol，2002，100(1)：3-7.
[8] Cramer SF，Marchetti C，Freedman J，et al. Relationship of myoma cell size and menopausal status in small uterine leiomyomas[J]. Arch Pathol Lab Med，2000，124(10)：1448-1453.
[9] Templeman C，Marshall SF，Clarke CA，et al. Risk factors for surgically removed fibroids in a large cohort of teachers[J]. Fertil Steril，2009，92(4)：1436-1446.
[10] Polatti F，Viazzo F，Colleoni R，et al. Uterine myoma in postmenopause：a comparison between two therapeutic schedules of HRT[J]. Maturitas，2000，37(1)：27-32.
[11] Colacurci N，De Franciscis P，Cobellis L，et al. Effects of hormone replacement therapy on postmenopausal uterine myoma[J]. Maturitas，2000，35(2)：167-173.
[12] Palomba S，Sena T，Noia R，et al. Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas[J]. Obstet Gynecol，2001，98(6)：1053-1058.
[13] Akkad AA，Habiba MA，Ismail N，et al. Abnormal uterine bleeding on hormone replacement：the importance of intrauterine structural abnormalities[J]. Obstet Gynecol，1995，86(3)：330-334.
[14] Sayed GH，Zakherah MS，El-Nashar SA，et al. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia[J]. Int J Gynaecol Obstet，2011，112(2)：126-130.
[15] Magalh?es J，Aldrighi JM，de Lima GR. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas[J]. Contracept，2007，75(3)：193-198.
[16] Friedman AJ，Rein MS，Harrison-Atlas D，et al. A randomized，placebo-controlled，double-blind study evaluating leuprolide acetate depot treatment before myomectomy[J]. Fertil Steril，1989，52(5)：728-733.
[17] Bagaria M，Suneja AN，Guleria K，et al. Low-dose mifepristone in treatment of uterine leiomyoma：a randomized double-blind placebo-controlled clinical trial[J]. Aust N Z J Obstet Gynaecol，2009，49(1)：77-83.
[18] Shen Q，Hua Y，Jiang W，et al. Effects of mifepristone on uterine leiomyoma in premenopausal women：a meta-analysis[J]. Fertil Steril，2013，100：1722-1726.
[19] 贾柠伊，冯力民. AAGL子宫次全切除术的临床指南解读[J]. 国际妇产科学杂志，2014，41(5)：578-580.
[20] 谢庆煌，柳晓春，郑玉华. 非脱垂子宫阴式子宫全切术的适应证和禁忌正探讨[J]. 中华妇产科杂志，2005，40(7)：441-444.
[21] 李孟慧，冷金花，史精华，等. 腹腔镜与开腹子宫肌瘤剔除术后肌瘤残留、复发及妊娠结局的比较[J]. 中华妇产科杂志，2011，46(9)：669-673.
[22] Rossetti A，Sizzi O，Soranna L，et al. Long -term results of laparoscopic myomectomy：recurrence rate incomparison with abdominal myomectomy[J]. Hum Reprod，2001，16 (4)：770-774.
[23] Seracchioli R，Rossi S，Govoni F，et al．Fertility and obstetric outcome after laparoscopic myomectomy of large myomata：a randomized comparison with abdominal myomectomy[J]. Hum Reprod，2000，15(12)：2663-2668．
[24] Wu F，Wang ZB，Zhu H，et al. Extracorporeal high intensity focused treatment for patients with breast cancer[J]. Breast Cancer Res Treat，2005，9（2）：51-60.
[25] Cheung VYT. Sonographically guided high-intensity focused ultrasound for the management of uterine fibroids[J].J Ultrasound Med，2013，32(8)：1353-1358.
[26] Bum PR，Mccall JM，Chinn RJ，et al．Uterine fibroleiomyoma：MR imaging appearances before and after embolization of uterine arteries[J]．Radiology，2000，214(3)：729-734．
[27] Popovic M，Berzaczy D，Puchner S，et al．Long-term quality of life assessment in patients undergoing uterine fibroid embolization[J]. AJR，2009，193(1)：267-271.
（2015-11-30收稿）
/
| 〈 |
|
〉 |
